Multiple sclerosis patients with higher B cell counts found to have a better vaccine response
Multiple sclerosis (MS) patients treated with Rituximab have better responses to the COVID-19 vaccine if they have higher B cell counts. This is the finding of a study from Uppsala University published in the journal JAMA ...
May 12, 2022
0
65